U.S. markets close in 4 hours 56 minutes
  • S&P 500

    4,234.56
    +9.77 (+0.23%)
     
  • Dow 30

    33,896.51
    +19.54 (+0.06%)
     
  • Nasdaq

    14,167.40
    +25.92 (+0.18%)
     
  • Russell 2000

    2,273.41
    -12.68 (-0.55%)
     
  • Crude Oil

    73.59
    -0.07 (-0.10%)
     
  • Gold

    1,778.20
    -4.70 (-0.26%)
     
  • Silver

    25.83
    -0.19 (-0.73%)
     
  • EUR/USD

    1.1906
    -0.0018 (-0.15%)
     
  • 10-Yr Bond

    1.4800
    -0.0040 (-0.27%)
     
  • GBP/USD

    1.3918
    -0.0015 (-0.11%)
     
  • USD/JPY

    110.7110
    +0.4130 (+0.37%)
     
  • BTC-USD

    30,420.66
    -2,382.82 (-7.26%)
     
  • CMC Crypto 200

    725.75
    -68.57 (-8.63%)
     
  • FTSE 100

    7,081.39
    +19.10 (+0.27%)
     
  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·7 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

For Immediate Release

Chicago, IL – September 8, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Humana Inc. HUM, Select Medical Holdings Corp. SEM, Universal Health Services, Inc. UHS and Fresenius SE & Co FSNUY.

Here are highlights from Friday’s Analyst Blog:

How to Invest After the Market Selloff

If you’re concerned about the way shares dropped off sharply yesterday, you should be.

This kind of volatility is what we’ve been talking about for a while now, so it should be something we are preparing for rather than something that surprises us.

It’s clear that there has been some profit taking, considering the long weekend coming up and the weather that generally has people visiting the great outdoors. And it has been really profitable for investors of late, what with valuations going through the roof. So it’s natural that they’d want to use some of that cash.

But it may not be the only reason. It is a fact that the economy is doing well and appears set to do better. Also, the pandemic isn’t spreading like it was earlier and a vaccine is around the corner. So a growing number of markets are going to open up.

This, of course, means that the tech sector won’t be playing as big a role as it has in the past few months. But given the prices these shares are trading at, there’s bound to be some negative reaction as money starts flowing into other areas.

This will increase the volatility that’s already expected as the nation goes to the polls, in addition to the government’s recently-adjusted attitude to inflation.

So if you’re looking for a good strategy for investing in stocks, I can tell you that the best strategies are the tried and tested ones. So here at Zacks, that means stocks with #1 (Strong Buy) or #2 (Buy) ranks; operating in attractive industries (the top 50% of Zacks–classified industries outperform the bottom 50% by a factor of more than 2 to 1); with good Growth or Value Scores and attractive numbers to match.

I’ve selected a few from the medical sector here that you may want to add to your portfolio-

Humana Inc.

Humana is one of the largest health care plan providers in the United States. It offers health insurance benefits under Health Maintenance Organization (HMO), Private Fee-For-Service (PFFS), and Preferred Provider Organization (PPO) plans. Its specialty products deal with dental, vision and other supplementary benefits. Its plans reach people through a network of healthcare providers.

At the end of 2019, it had around 17 million members under its medical benefit plans and approximately 5 million members in its specialty product category.

Zacks Rank #2

Value B

Growth A

Industry: Medical - HMOs (top 13%)

Revenue to grow 15.6% and 8.9%, respectively in this year and the next

EPS to grow 5.0% and 17.4%, respectively in this year and the next

Valuation: P/S is 0.80X, suggesting undervaluation

Select Medical Holdings Corp.

Select Medical owns critical illness recovery and rehabilitation hospitals. It also offers outpatient rehabilitation and occupational health services. As of Dec 31, 2019, it operated 101 critical illness recovery hospitals in 28 states, 29 rehabilitation hospitals in 12 states, and 1,740 outpatient rehabilitation clinics in 37 states and the District of Columbia.

Zacks Rank #1

Value A

Growth A

Industry: Medical - HMOs (top 13%)

Revenue to grow -2.4% and 6.6%, respectively in this year and the next

EPS to grow 8.9% and 24.8%, respectively in this year and the next

Valuation: P/S is 0.51X, suggesting undervaluation

Universal Health Services, Inc.

 Universal Health Services owns and operates (through its subsidiaries) acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

It offers general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.

Its 350 inpatient acute care hospitals and behavioral health facilities and 37 outpatient and other facilities are located in 37 states, Washington, D.C., the UK, Puerto Rico and the U.S. Virgin Islands.

Zacks Rank #1

Value A

Growth A

Industry: Medical - Hospital (top 26%)

Revenue to grow -1.4% and 6.0%, respectively in this year and the next

EPS to grow -5.8% and 11.0%, respectively in this year and the next

Valuation: P/S is 0.85X, suggesting undervaluation

Fresenius SE & Co

Fresenius  offers products and services for dialysis through hospitals and outpatient treatment. Its Fresenius Medical Care segment treats chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services; and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.

Zacks Rank #2

Value A

Growth A

Industry: Medical - Instruments (top 23%)

Revenue to grow 8.3% and 4.7%, respectively in this year and the next

EPS to grow -1.1% and 10.7%, respectively in this year and the next

Valuation: P/S is 0.65X, suggesting undervaluation

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021. 

Click here for the 6 trades >>

Join us on Facbook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                       

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
 
Humana Inc. (HUM) : Free Stock Analysis Report
 
Select Medical Holdings Corporation (SEM) : Free Stock Analysis Report
 
FRESENIUS SECO (FSNUY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research